ArticleCancer immunology, immunotherapy : CII2024

Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma.

Jin Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.